GE HealthCare Technologies Inc.

Company facts

Industry

X-Ray Apparatus & Tubes & Related Irradiation Apparatus

Headquarters

Chicago, Illinois

Most recent report

8-K, filed Nov 5, 2026

Incorporated

Delaware

Filings on record

446 filings

On EDGAR

CIK 1932393

Fiscal year ends

December

Filer status

Large accelerated filer

What to read: Sep 2026 10-Q

SECSift found 2 of 13 sections worth reading, with 1 positive, 4 notable, and 2 negative flags.

• Financial Statements (Item 1)

  Large acquisition, segment change, cash burn, and IRS tax exposure.
  Notable

  • Post-acquisition: $2.3B Intelerad deal closed March 2026, funded by debt and cash.
  • Share repurchases paused in Q3 2026; $500M still authorized under the $1B program.
  • Tariff refunds: $115M pre-tax benefit in nine months ended Sept 30, 2026 from IEEPA tariff refunds.

• Management's Discussion (Item 2)

  Tariffs materially hit operating income and cash flows; segment results diverge sharply.
  Positive

  • PDx segment revenue grew 16.5% ($348M) in nine months ended Sep 2026, driven by volume and price.
  Notable

  • Investing cash outflow surged to $2.7B in nine months ended Sep 2026, mainly for Intelerad acquisition ($2.3B).
  Negative

  • Direct tariffs cut operating income by $209M in nine months ended Sep 2026; refunds only partly offset.
  • PCS segment revenue fell 4.0% ($91M) in nine months ended Sep 2026 due to operational and fulfillment challenges.

What changed: Sep 2026 vs. Jun 2026

About 1% of GEHC's Sep 2026 10-Q is new information. 2 paragraphs were added, 189 changed, and 26 removed. Below are the most important lines SECSift identified.

• Item 2 78
• Item 1 53
• Item 4 2
• Item 6 2